Applied Biostatistics using STATA

---

LIVEWEBINARDHPAMA

Sunday, May 28, 2023, 4:00 PM - Wednesday, May 31, 2023, 6:00 PM, Livestreamed via Zoom

This will be 4 two-hours sessions with application on the use of STATA for biostatistical analysis. Session 1: includes introduction to STATA, computing summary statistics (mean, median mode, interquartile range, min, max, standard deviation, and frequency distribution) and creating graphs such as histogram, pie chart, column chart, box plot and scatter plots. Session 2: includes performing analysis on a numerical continuous outcome. This includes one sample t-test, paired sample t-test, independent sample t-test, confidence interval for one mean and confidence interval for the difference between two means. Session 3: includes performing analysis on a dichotomous outcome. This includes the proportion test, the binomial test, Chi-squared test, Fisher's exact test, and McNemar's test. Session 4: includes introduction to univariate and multivariable linear and logistic regressions. All sessions will include application using case studies.

1. Apply univariable and multivariable statistical methods for numeric and categorical outcomes using STATA.

• Early Bird (valid until April 28, 2023): 96 USD - 350 QAR
• Regular Fees (from April 29, 2023): 137 USD - 500 QAR

The registration closes ONE day before the activity. You will receive a UNIQUE join link on the day of the presentation.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to cpd@qatar-med.cornell.edu.

Changes or Cancellations

• Name changes or substitutions are not permitted.
• All cancellation and refund requests must be made in writing and submitted via email to cpd@qatar-med.cornell.edu.
• For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
• We will attempt to process the refund within 30 days of receiving any cancellation request.
• Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions. 

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 8 hours.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Ziyad R. Mahfoud, PhD, Thurayya Arayssi, MD, Bruce MacRae, MSc, RRT, Vahe Kehyayan, MSN, PhD, Phyllis Sui Muffuh Navti, Doctorate in Pharmacy Practice, Hatem Algraffee, BDS, have no relevant financial relationships to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Faculty: Ziyad R. Mahfoud, PhD, has no relevant financial relationships to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

Administrative Contact: Safia Rabia has no relevant financial relationships to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.